The Prominent Expected National Press Exposure Has Commenced!23 Aug 2021 23:59
"Abingdon Health was the big winner on the stock market following the launch of an at-home Covid antibody test.
The AIM-listed group is working in partnership with BioSure, the firm behind the first rapid self-HIV test, on the coronavirus kit.
It is all systems go at Abingdon's manufacturing centres in York and Doncaster to get as many of the BioSure antibody tests off the assembly line as possible.
In the UK, the rapid and successful rollout of Covid vaccines means officials are now hoping that individuals will be able to take a more proactive role in tracking the pandemic.
Antibody tests measure the levels of the immune cells produced by a person's body in response to the coronavirus – whether they caught it naturally or had a vaccination.
Understanding these levels could be a useful way to determine who needs booster jabs and who is or might become especially vulnerable should there be later waves.
BioSure's test requires a finger prick of blood and can provide results in 20 minutes. The tests are not too pricey – a single pack is £32.95 and for a family-of-four it is £100.
As Chris Yates, Abingdon's chief executive has previously said, it is imperative to monitor lowering – or as he describes it, 'neutralising' – antibody levels 'in the worldwide population to maintain the safety of the public and instil confidence in people as they return to normal life'.
Abingdon's shareholders cheered news of the launch, with shares rocketing 96.7 per cent, or 29.5p, to 60p last night."
https://www.dailymail.co.uk/money/markets/article-9920089/MARKET-REPORT-Abingdon-antibody-test-gets-marks.html
Sign In
Follow the stocks
